ALKS

Alkermes
ALKS

Latest price

Financial Snapshot

gainify

Market Data

Market Cap
$4.48B
EV
$3.80B
Shares Outstanding
164.84M
Beta
0.35

Wall Street View

Analyst Rating
OUTPERFORM
Analyst Target Price
$39.71
P/E 2025E
15.20x
P/Revenue 2025E
3.22x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Alkermes plc

gainify
ALKS

Alkermes plc

ALKS

Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in therapeutic areas in the United States, Ireland, and internationally. It has a portfolio of proprietary commercial...

Sector

Healthcare

Industry

Biotechnology

CEO

Pops, Richard

Employees

1,800

IPO Date

1991-07-16

Headquarters

Connaught House, 1 Burlington Road, Dublin 4, Dublin, Co. Dublin, D04 C5Y6, Ireland

gainify
mailcontactcontact
powered-by-sp

NEWSLETTER

COMPANY

© Copyright 2025, All Rights Reserved